Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tyra Biosciences, Inc.

10.39
-0.4700-4.33%
Post-market: 10.810.4200+4.04%17:24 EDT
Volume:104.20K
Turnover:1.10M
Market Cap:552.52M
PE:-6.36
High:11.19
Open:11.00
Low:10.38
Close:10.86
Loading ...
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 19, 2024

Correspondence

Form CORRESP - Correspondence
Mar 19, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 19, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 08, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities